PCN92 Cost Effectiveness of Obinutuzumab PLUS Chemotherapy Followed By Obinutuzumab Maintenance for Patient with Previously Untreated Advanced-STAGE Follicular Lymphoma in French Setting
Abstract
Authors
B. Mazaleyrat F. Boissard S. Ayad A. Launonen